Country Chair, Sanofi Kazakhstan
General Manager RX, Sanofi Central Asia
Vitaly is Country Chair, Sanofi Kazakhstan and General Manager RX, Sanofi Central Asia since August 2019. He has more than 18 years of managerial experience in pharmaceutical industry, where he has held various positions in global pharmaceutical companies. Prior to joining the Sanofi Central Asia Team, Vitaly was the Sanofi Diabetes Business Unit Head in Russia.
Since 2013, Vitaly has implemented several successful transformational projects at Sanofi, has modified a business model and structure of the business unit, and made a significant contribution into the development of a culture of affiliate. As a Head of Diabetes franchise, Vitaly successfully launched one of key innovative products. This launch got the International Award as the Sanofi best launch in the world.
Vitaly is a graduate of Chelyabinsk State Medical Academy as Anesthesiologist-Resuscitator, and has an MBA Degree from the Moscow International Higher Business School (MIRBIS).
Roger Elia is the General Manager of Merck Biopharma in CIS
Born in 1976 in Lebanon. Roger holds MBA in Finance & Marketing. Roger lived and worked in Lebanon, Russia, CIS and South Korea. Since 2018 he has been living and working in Russia.
2018 – now
General Manager of Merck Biopharma in CIS
Business Unit Head at Merck Ltd Korea
2014 – 2015
Strategic Alliance Leader at Merck LLC Russia
2011 – 2014
Marketing Manager at Merck LLC Russia
Market Access and Pricing Head at Novartis Oncology Russia
Various management positions at Pharmonyx Ltd in Russia and CIS
1994 – 2003
Medical Academy, Moscow
As an engagement manager (Russia & CIS), Olga is Responsible for leading and management of consulting project and business development in Russia and CIS countries
More than 10 years experience in Pharmaceutical and Chemical industries with focus on Strategy & Business development, operational and commercial excellence
Expertise in identifying and evaluation of portfolio expansion and acquisition opportunities, potential assessment, pricing and market access, new geography expansion and strategy development, marketing strategies and consumer health, supply chain and demand planning
Before joining IQVIA in 2014 worked as Strategy Development manager in Russian chemical company and Novartis Consumer Health
Graduated from Lomonosov Moscow State University with Master of Science degree in Mathematics and completed Business Academy in Stockholm School of Economics
Marina Durmanova is the President of the Republic of Kazakhstan Pharmaceutical Activity Support and Development Association the participants of which are the national and foreign pharmaceuticals manufacturers, distribution companies and pharmacy organizations. Represented by Marina Durmanova, the Association takes an active part in standard setting process. She is a member of the task groups under the Mazhilis (the lower house) of the Parliament that discuss various draft laws in the public health sphere.
The Association s a member of the Social Council under the Republic of Kazakhstan Public Health Ministry, National Scientific Council operating in the sphere of the life science and health with pharmaceutical science as the priority line, Republic of Kazakhstan Public Health Ministry’s collegium, formulary commission under the RK Public Health Ministry, Expert and Business Council under the Almaty Akimat (City Executive Board). She has been accredited by the Republic of Kazakhstan National Chamber of Entrepreneurs and is a member of the Pharmaceutical and Medical Industry Committee under the RK NCE Atameken.
The Republic of Kazakhstan Pharmaceutical Activity Support and Development Association is a member of the task group in charge of development of general approach to control of pharmaceuticals and medical products circulation within the boundaries of the Customs Union and the Common Economic Area.
Marina Durmanova has repeatedly received state awards for her contribution to development of the national public health sphere.
Medical doctor and marketer, graduated from the Plekhanov Russian University of Economics (Moscow), PhD.
In the pharmaceutical industry since 2007. In Nycomed (later – Takeda) he has grown from the 1st Medical representative for the Kyrgyzstan southern region to the Representative Office in Uzbekistan Head, created the Asia-Caucasus Cluster Medical department, successfully developed the cardiology portfolio by 3 products launch to the Kazakhstani market.
In Chimpharm JSC (Santo, Polpharma group) cardiology division has raised on the relevant market from the 4th position to the 2nd when he managed the Rx Marketing department. He also participated in the corporate project group for launches strategies and mechanics.
In the Acino Kaz LLP he is in charge of oncology and paediatric endocrinology.
Sergei Groshev has been administrating the Facebook page for head and neck cancer early signs, was awarded with the Saint-Petersburg Government Committee for Youth Politic and Collaboration with Public Organizations, has been passed to the semi-final of Leaders of Russia-2020 (the Public Health course).
Dr. Aleksandr Solodovnikov has 14 years of clinical trial expertise as an investigator, CRA, clinical operations trial lead and clinical operations manager in fields of Endocrinology, Psychiatry, Cardiology, Pulmonology, Oncology, Hematology, Dermatology, Neurology, Surgery and Infectious Diseases (more than 30 trials, phase I-IV).
Aleksandr graduated from the Ural State Medical Academy (now University) in 2003 and started his scientific career at the Chair of preventative and family medicine resulting in a PhD in Rheumatology in 2009. Dr. Solodovnikov is now an associate professor of this Chair supervising edivence-based medicine and biostatistics fields. Aleksandr received his training in statistics and epidemiology at the University of Manchester, UK, and at the Erasmus University, the Netherlands, and personally prepared and conducted more than 300 various statistical analyses in various statistical software packages (NCSS, Stata, R, SPSS, Statistica and other) and provided a lot of consultations in this field. He further developed his professional skills in clinical research by taking the “Principles and Practice of Clinical Research” course at Harvard Medical School in 2014. In 2016, Aleksandr also successfully completed the “Project Management Professional”.
Dr. Solodovnikov is a skillful trainer and lecturer, and has conducted numerous GCP trainings as well as seminars in biostatistics, evidence-based medicine, clinical research, drug development and regulations in clinical trials. He knows local, regional (EAEU) and international clinical trial regulations and guidelines well, and took part in the development of hundreds of clinical trial documents for medicines, medical devices, cosmetic and dietary products, and biologically active substances, starting from study concept and ending with the final protocol.
Nataliia Dekhno graduated from Т. Shevchenko Kyiv National University with Master’s degree in Economics in 2006.
She has 6 years’ experience in marketing in FMCG sphere with such international companies as METRO C&C and Henkel and 7 years of independent brand management experience in OTC pharmaceutics. As professional marketeer she has deep knowledge of Pharmaceutical industry in Ukraine and proved track of records in different categories.
In 2015 Nataliia graduated from Netherlands Institute of Marketing; she has complied with EMC Qualifications Framework Standards and therefore was recognized as Marketing Manager.
In her current position as Business Development Manager in GSK Consumer Health she is responsible for implementation of business development and market access initiatives in UA&CIS, such as big country or category or brand growth and project management initiatives to drive simplification agenda. In parallel she manages local NPI & Artwork team and artwork process. Nataliia is responsible for integration to Eurasian Economic Union for all countries including Russia.
Irina Ivanishcheva was appointed to the position of Corporate Affairs and Legal Director, AstraZeneca Russia & Eurasia in 2016. In her role, Irina provides legal support to the entire region and is responsible for communication with the government authorities and developing internal and external communications in Russia and Eurasia.
Irina joined AstraZeneca in 2002. In 2006, she started to work in the legal department and after one year became the Head of the department. Irina has achieved impressive results during her time at AstraZeneca. Her efforts helped to shape the work of the legal department, which provides comprehensive support in matters concerning corporate, commercial, labour, and antitrust law to AstraZeneca’s business in Russia and Eurasia.
Irina has two university degrees. She graduated from National Research University of Electronic Technology and the State University of Management with a major in law.
He advises and leads projects for many multinational companies in pharmaceutical, healthcare, consumer goods, information and technology industries on various matters including commercial, employment, tax, customs, intellectual property and litigation.
Shakhrukh has an extensive experience on representation of pharmaceutical clients in negotiations with state authorities and third parties. He also successfully supervised representation of clients interests in a wide variety of judicial disputes in the Republic of Kazakhstan, both commercial and those in relation to actions of state authorities.
BABANOVA KYNABU TOKTOGULOVNA (born June 30, 1964) is the founder and general director of one of the leading pharmaceutical companies in Kyrgyzstan, LLC BIMED Pharm and KSK Company, specializing in the retail and wholesale of medicines.
Education - higher medical. Graduated from the Kyrgyz State Medical Institute (KSMI) in Frunze, Faculty of Pediatrics in 1986.
She began her career in 1986 as an intern at the Department of Psychiatry and Narcology at KSMI.
In the period from 1987 to 1994 she worked in various positions in the medical institutions of the Kirov district in Talas. She has gone from an intern doctor to the head of the Department of the Narcological Dispensary in Talas.
In 1994, she was appointed deputy director of the ASEM commercial firm, where she worked until 1997.
In August 1997, Babanova Kynabu Toktogulovna founded her own drug retail company Nasip LLC. At the initial stages, the company owned one pharmacy covering an area of 107 sq.m. and included three employees.
Alexey brings 10 years of consulting experience across a variety of sectors with focus on healthcare and pharmaceutical industry in Russia, Ukraine, Kazakhstan and globally in Europe
Alexey has been a part of 100+ projects on strategic, commercial, marketing and manufacturing issues with multinational and local clients in healthcare
Before joining IQVIA he worked for KPMG Strategy leading strategic and operational projects
MBA from IE Business School (Madrid), MA and BA from Higher School of Economics (Moscow)
Evgeniy Kunda built a successful career in Proxima Research LLC, starting with the position of the analyst to the Commercial director of Proxima Research International.
Over 15 years he has been involved in the management and participates in the project`s development.
His achievement is the expansion of the information space in the CIS countries.
Now, the main task of Evgeniy is to optimize existing services and business processes, build effective communication with global IT vendors and Proxima`s business partners, formation of a development strategy, search for and launch innovative SFE-solutions for the Pharma market.
Head of Government Relations Department, GEROPHARM
Vilena graduated from the State University of Management with a degree in Public Relations in 2008. In 2018, she completed additional education at the St. Petersburg State Chemical and Pharmaceutical University, Department for Regulation of Circulation of Medicines in Pharmaceutical Market.
Her professional experience in pharmaceutical business goes back to 2008. She worked in consulting companies cooperating with major international and Russian companies.
In 2012, she joined GEROPHARM. Vilena is an expert and a regular participant in discussions on topical issues related to industry regulation.
President of Association of Manufacturers of Pharmaceuticals of the RA (ArPharMa)
Taguhi Piruzyan graduated from the Faculty of International Relations of Yerevan State University in 2012, and of the Faculty of Law and Politics of Russian-Armenian (Slavonic) University in 2014, she received also Master’s degree in Law in 2016. She also participated in a number of projects in EU.
She worked at DAENA Accounting and Law Сenter (2013-2014), was the Head of the Department of Historical and Cultural Monuments Protection under the MoC of the RA (2014-2015), worked also in the Armenian Parliament, Municipality of Yerevan, NGO for the defence of human rights.
In 2017, she became a member of the Chamber of Advocates of the RA, and started working at №1 Attorney Office. In 2018, she co-founded Piruzyan Law Company.
She is also a Chief Legal Adviser at Yeghiazaryan & Partners Law Firm since 2019.
In April 2019, she was elected as a President of Association of Manufacturers of Pharmaceuticals of the RA.
Vaghinak Grigoryan was born in 1989 in Yerevan, Armenia. Holds a Master's Degree in Pharmacy. GMP/GDP coordinator and auditor.
2020 - now Deputy General Director for Quality at "Esco Pharm" Ltd. (Yerevan, Armenia)
2018 - now Quality Manager at "Esculap" Ltd (Yerevan, Armenia)
2015-2020 - Head of Quality Assurance at "Esco Pharm" Ltd (Yerevan, Armenia)
2014-2015 - Sales manager at "OTC Pharma" (Vladivostok,Russia)
2012-2014 - Senior Pharmacist at "Lotus" Medical Centre (Abu Dhabi, UAE)